Table 1 Characteristics of HCC patients treated by resection.

From: The lymphocyte-to-monocyte ratio is a superior predictor of overall survival compared to established biomarkers in HCC patients undergoing liver resection

Characteristic

LMR < 4.01 N = 341

LMR ≥ 4.01 N = 311

P

Gender, M/F

299/42

267/44

0.490

Age, yr

48.01 ± 11.5

46.9 ± 11.3

0.200

HBsAg

  

0.526

   Negative

52

42

 

   Positive1

289

269

 

Liver cirrhosis

  

0.529

   No

60

49

 

   Yes

281

262

 

AFP, ng/mL

  

<0.001

   <400

134

209

 

   ≥400

207

102

 

BCLC stage

  

0.130

   0 or A

175

178

 

   B or C

166

133

 

Edmonson grade

  

0.411

   I–II

116

268

 

   III–IV

73

195

 

Child-Pugh class

  

0.533

   A

322

297

 

   B

19

14

 

Tumor number

  

0.010

   Single

225

234

 

   Multiple

116

77

 

Tumor size,cm

7.7 ± 3.7

6.1 ± 3.1

<0.001

Tumor capsule

  

0.172

   Complete

129

134

 

   Incomplete

212

177

 

Albumin, g/L

39.6 ± 4.2

40.5 ± 5.0

0.009

Platelet count, 109/L

122.4 ± 65.4

89.0 ± 42.3

0.040

AST, U/L

49(34–72)

39(30–53)

<0.001

ALT, U/L

41(28.5–56.5)

39(28–56)

0.253

Total bilirubin, μmol/L

13.1(9.7–17.6)

13.4(9.2–17.4)

0.789

NLR

  

<0.001

   <2.78

203

282

 

   ≥2.78

138

29

 

PLR

  

<0.001

   <99.5

147

210

 

   ≥99.5

194

101

 
  1. Data are mean ± standard deviation or median (25th–75th interquartile range) unless otherwise indicated.
  2. Abbreviations: HBs Ag, hepatitis B surface antigen; AFP, alpha-fetoprotein; BCLC, Barcelona Clinic Liver Cancer; AST, aspartate aminotransferase; ALT, alanine aminotransferase; HCC, Hepatocellular Carcinoma.
Back to article page